澳门金沙游戏

Founded in 2006, Qiming is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen and Hong Kong. In 2017, Qiming raised its first US fund, and set up Qiming’s US offices in Seattle, Boston and Palo Alto. Currently Qiming manages seven US Dollar funds and five RMB funds with US$4 billion assets under management.


Qiming strives to be the investor of choice for top entrepreneurs in China. Since our debut, we have backed over 280 young, fast-growing and innovative companies across China in the internet and consumer ("Intersumer"), healthcare, information technology and clean technology sectors. Over 50 of them are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange, and Shenzhen Stock Exchange or achieved exit through M&A. There are also nearly 20 portfolio companies that have been recognized as unicorns in the industry. And many of our portfolio companies are today’s most influential brands in their respective sectors, including Xiaomi (HK 01810), Meituan-Dianping, TutorGroup (VIPABC), Meili Inc., Meitu (HK 01357), Bilibili (Nasdaq BILI), Tigermed (SZ 300347), Gan & Lee, Zai Lab (Nasdaq ZLAB), Hexing (SH 603556), CSD (SH 603903), Tellgen (SZ 300642), AmoyDx (SZ 300685), Berry Genomics (SZ 000710), HyperStrong, We Doctor Group, Face++, UBTech, Mobike and JingChi. Qiming consistently ranks among the top venture firms in terms of returns to its investors.


Qiming drives innovation and growth of business enterprises and promotes overall industry advancement and social development. With access to our partners’ experience and global network as well as our excellent industry background, we spare no efforts in helping our entrepreneurs and their companies succeed!

IN KEY INDUSTRIES

  • INTERSUMER

  • HEALTHCARE

  • INFORMATION TECHNOLOGY

  • CLEAN TECH

申博代理开户合作登入 申博138娱乐直营网 申博开户网登入 申博管理登入 申博开户网登入 申博官网
百家乐微信支付充值 申博代理登录登入 申博电子娱乐 申博太阳城娱乐中心直营网 太阳城申博娱乐www.sbc66.com 菲律宾申博老虎机直营
www.msc66.com 菲律宾申博红太阳娱乐直营网 旧版太阳城申博开户 申博支付宝充值 申博菲律宾太阳城88登入 申博登录不了